| Reference |
|---|
Raghavan R, Friedrich M, King I, Chau Duy Tam Vo S, Strebinger D, Lash B, et al. Rational engineering of minimally immunogenic nucleases for gene therapy. Nat Commun. 2025;16:105 pubmed publisher |
Hayashi H, Mak T, Tanaka Y, Kubo Y, Izumida M, Urae R, et al. Development of a highly sensitive platform for protein-protein interaction detection and regulation of T cell function. Proc Natl Acad Sci U S A. 2024;121:e2318190121 pubmed publisher |
Dobersalske C, Rauschenbach L, Hua Y, Berliner C, Steinbach A, Gr xfc neboom A, et al. Cranioencephalic functional lymphoid units in glioblastoma. Nat Med. 2024;30:2947-2956 pubmed publisher |
Li L, Qin R, Liu Y, Tseng Y, Zhang W, Yu L, et al. Dissecting positive selection events and immunological drives during the evolution of adeno-associated virus lineages. PLoS Pathog. 2024;20:e1012260 pubmed publisher |
Vos J, Burman B, Jain S, Fitzgerald C, Sherman E, Dunn L, et al. Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. Nat Med. 2023;29:3077-3089 pubmed publisher |
Mai F, Volzke J, Reisinger E, M xfc ller Hilke B. Vaccine-Induced T-Cell and Antibody Responses at 12 Months after Full Vaccination Differ with Respect to Omicron Recognition. Vaccines (Basel). 2022;10: pubmed publisher |
Menges D, Zens K, Ballouz T, Caduff N, Llanas Cornejo D, Aschmann H, et al. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort. Nat Commun. 2022;13:4855 pubmed publisher |
M xfc ller Hilke B, Mai F, M xfc ller M, Volzke J, Reisinger E. Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2. Vaccines (Basel). 2022;10: pubmed publisher |
Mysore V, Cullere X, Mears J, Rosetti F, Okubo K, Liew P, et al. FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity. Nat Commun. 2021;12:4791 pubmed publisher |
Tripiciano A, Picconi O, Moretti S, Sgadari C, Cafaro A, Francavilla V, et al. Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART. EBioMedicine. 2021;66:103306 pubmed publisher |
Wang X, Ji D, Zhu B, Jiang S, Han L, Wang Y, et al. Contribution of endotoxin to Th17 bias in patients with non-alcoholic steatohepatitis. Microb Pathog. 2020;142:104009 pubmed publisher |
Taghinezhad S S, Mohseni A, Keyvani H, Razavi M. Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine. Mol Ther Methods Clin Dev. 2019;15:40-51 pubmed publisher |
Mohseni A, Taghinezhad S S, Keyvani H. The First Clinical Use of a Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E7 Oncogene Oral Vaccine: A Phase I Safety and Immunogenicity Trial in Healthy Women Volunteers. Mol Cancer Ther. 2020;19:717-727 pubmed publisher |
Peng S, Zaretsky J, Ng A, Chour W, Bethune M, Choi J, et al. Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood. Cell Rep. 2019;28:2728-2738.e7 pubmed publisher |
Pang Y, He J, Cui B, Xu S, Li X, Wu M, et al. A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cells Int. 2019;2019:5680327 pubmed publisher |
Yang W, Lee K, Srivastava R, Kuo F, Krishna C, Chowell D, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25:767-775 pubmed publisher |
Zhao J, Shiratori B, Chagan Yasutan H, Matsumoto M, Niki T, Tanaka M, et al. Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis. Int J Mol Sci. 2017;18: pubmed publisher |
Ren J, Liu X, Fang C, Jiang S, June C, Zhao Y. Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition. Clin Cancer Res. 2017;23:2255-2266 pubmed publisher |
Hagen J, Zimmerman R, Goetz C, Bonnevier J, Houchins J, Reagan K, et al. Comparative Multi-Donor Study of IFNγ Secretion and Expression by Human PBMCs Using ELISPOT Side-by-Side with ELISA and Flow Cytometry Assays. Cells. 2015;4:84-95 pubmed publisher |
Nogueira R, Gomes Silva A, Bittar R, Silva Mendonça D, Amato V, da Silva Mattos M, et al. Antigen-triggered interferon-? and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease. Clin Exp Immunol. 2014;177:679-86 pubmed publisher |
Umlauf B, Ovsyannikova I, Haralambieva I, Kennedy R, Vierkant R, Pankratz V, et al. Correlations between vaccinia-specific immune responses within a cohort of armed forces members. Viral Immunol. 2011;24:415-20 pubmed publisher |
Poirier N, Haudebourg T, Brignone C, Dilek N, Hervouet J, Minault D, et al. Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates. Clin Exp Immunol. 2011;164:265-74 pubmed publisher |
Correale J, Farez M. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol. 2009;183:5999-6012 pubmed publisher |
Fan K, Borden E, Yi T. Interferon-gamma is induced in human peripheral blood immune cells in vitro by sodium stibogluconate/interleukin-2 and mediates its antitumor activity in vivo. J Interferon Cytokine Res. 2009;29:451-60 pubmed publisher |
Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci U S A. 2009;106:8302-7 pubmed publisher |
McAulay K, Haque T, Urquhart G, Bellamy C, Guiretti D, Crawford D. Epitope specificity and clonality of EBV-specific CTLs used to treat posttransplant lymphoproliferative disease. J Immunol. 2009;182:3892-901 pubmed publisher |
Longo O, Tripiciano A, Fiorelli V, Bellino S, Scoglio A, Collacchi B, et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine. 2009;27:3306-12 pubmed publisher |
Ysrraelit M, Gaitán M, Lopez A, Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology. 2008;71:1948-54 pubmed publisher |
Hirosako S, Goto E, Fujii K, Tsumori K, Hirata N, Tsumura S, et al. Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells. Clin Exp Immunol. 2009;155:266-74 pubmed publisher |
Deniz G, Erten G, Kucuksezer U, Kocacik D, Karagiannidis C, Aktas E, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol. 2008;180:850-7 pubmed |
Correale J, Rush C, Amengual A, Goicochea M. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta. J Neuroimmunol. 2005;162:173-83 pubmed |
Bailey T, Stark S, Grant A, Hartnett C, Tsang M, Kalyuzhny A. A multidonor ELISPOT study of IL-1 beta, IL-2, IL-4, IL-6, IL-13, IFN-gamma and TNF-alpha release by cryopreserved human peripheral blood mononuclear cells. J Immunol Methods. 2002;270:171-82 pubmed |
